2100 WEST LOOP SOUTH, HOUSTON, TX
Market cap: $2.1M (2/11/2026)
Price: $3.70
Rami Levin Appointed CEO of CNS Pharmaceuticals Effective January 1, 2026
CNS Pharmaceuticals Approves 2020 Equity Plan Amendments at Annual Meeting
Annual Report to Security Holders
Announces Reverse Stock Split
Developing Anti - Cancer Drug Candidates for the Treatment of Primary and Metastatic Brain Cancers
News, Underwriting Agreement, Securities Holder Rights or Indentures, Material Contracts
Other Events
Q3
Q2
Q1
Amended Annual Report
FY 2024
Prospectus filed pursuant to Rule 424(b)(5)
Prospectus filed pursuant to Rule 424(b)(4)
Effectiveness Notice
Amended Registration Statement for Securities
S-1
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Definitive Revised Proxy Statement
Correspondence